[go: up one dir, main page]

TW200610529A - Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors - Google Patents

Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors

Info

Publication number
TW200610529A
TW200610529A TW094126968A TW94126968A TW200610529A TW 200610529 A TW200610529 A TW 200610529A TW 094126968 A TW094126968 A TW 094126968A TW 94126968 A TW94126968 A TW 94126968A TW 200610529 A TW200610529 A TW 200610529A
Authority
TW
Taiwan
Prior art keywords
kinase inhibitors
map kinase
triazolopyridinylsulfanyl
derivatives
disorder
Prior art date
Application number
TW094126968A
Other languages
Chinese (zh)
Other versions
TWI295926B (en
Inventor
John Paul Mathias
David Simon Millan
Russell Andrew Lewthwaite
Christopher Phillips
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of TW200610529A publication Critical patent/TW200610529A/en
Application granted granted Critical
Publication of TWI295926B publication Critical patent/TWI295926B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A compound of formula (I), or a pharmaceutically acceptable salt and/or solvate (including hydrate) thereof; and the use of a compound of formula (I) in the treatment of a TNF-mediated disease, disorder, or condition, or a p38-mediated disease, disorder, or condition, in particular the allergic and non-allergic airways diseases, more particularly obstructive or inflammatory airways diseases, preferably chronic obstructive pulmonary disease.
TW94126968A 2004-08-12 2005-08-09 Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors TWI295926B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0418015A GB0418015D0 (en) 2004-08-12 2004-08-12 New compounds
US69155905P 2005-06-17 2005-06-17

Publications (2)

Publication Number Publication Date
TW200610529A true TW200610529A (en) 2006-04-01
TWI295926B TWI295926B (en) 2008-04-21

Family

ID=33017410

Family Applications (1)

Application Number Title Priority Date Filing Date
TW94126968A TWI295926B (en) 2004-08-12 2005-08-09 Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors

Country Status (9)

Country Link
CN (1) CN101006087B (en)
GB (1) GB0418015D0 (en)
ME (1) ME01360B (en)
NI (1) NI200700039A (en)
PE (1) PE20060618A1 (en)
RS (1) RS50642B (en)
TW (1) TWI295926B (en)
UA (1) UA93032C2 (en)
ZA (1) ZA200700923B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2303267T3 (en) * 2008-02-04 2013-11-29 Pfizer Ltd Polymorphic form of a [1, 2, 4] triazolo [4, 3-a]pyridine derivative for treating inflammatory diseases
AU2010215261A1 (en) * 2009-02-17 2011-09-08 Chiesi Farmaceutici S.P.A. Triazolopyridine derivatives as p38 MAP kinase inhibitors
GB201009731D0 (en) * 2010-06-10 2010-07-21 Pulmagen Therapeutics Inflamma Kinase inhibitors
PE20141370A1 (en) * 2011-12-09 2014-10-17 Chiesi Farma Spa KINASE INHIBITORS
CN105693716A (en) * 2016-03-01 2016-06-22 孙霖 Crystal form A and preparing method
CN105646484A (en) * 2016-03-01 2016-06-08 孙霖 Crystal form B and preparation method

Also Published As

Publication number Publication date
ZA200700923B (en) 2008-09-25
TWI295926B (en) 2008-04-21
UA93032C2 (en) 2011-01-10
CN101006087A (en) 2007-07-25
GB0418015D0 (en) 2004-09-15
ME01360B (en) 2010-06-30
PE20060618A1 (en) 2006-07-14
CN101006087B (en) 2010-09-29
RS50642B (en) 2010-06-30
NI200700039A (en) 2008-03-07

Similar Documents

Publication Publication Date Title
MY140021A (en) Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors
TNSN08478A1 (en) Pyrazolo [3,4-d] pyrimidine derivatives useful to treat respiratory disorders
UA105014C2 (en) P38 map kinase inhibitors
PL1689391T3 (en) 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory airway diseases
SG179437A1 (en) Pyrimidine hydrazide compounds as pgds inhibitors
TNSN08104A1 (en) Pyrimidine amide compounds as pgds inhibitors
TW200500364A (en) Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors
MX2007014619A (en) Pyrrolopyridines useful as inhibitors of protein kinase.
MY147442A (en) Imidazoquinolines as lipid kinase inhibitors
UA115228C2 (en) Protein kinase inhibitors (variants), use thereof in treating oncological diseases and a pharmaceutical composition based thereon
ATE542800T1 (en) KINASE INHIBITORS AND THEIR METHODS OF APPLICATION
TW200616967A (en) Novel indazole carboxamides and their use
DK2046787T3 (en) Pyrazolo [3,4-B] pyridine compounds, and their use as PDE4 inhibitors
WO2007124369A3 (en) Method of inhibiting c kit kinase
TW200610529A (en) Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors
WO2006128674A3 (en) Combinations of indacaterol derivatives and other agents for the treatment of airway diseases
DE60203106D1 (en) AZOLYLCARBYNOL DERIVATIVES OF ARYL (OR HETEROARYL) FOR THE TREATMENT OF RESPIRATORY DISEASES
UY29057A1 (en) DERIVATIVES OF TRIAZOLOPIRIDINILSULFANILO AS QUINASA MAP P38 INHIBITORS
DOP2005000152A (en) DERIVATIVES OF TRIAZOLOPIRIDINILSULFANILO AS QUINASA MAP P38 INHIBITORS

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees